A fixation-compatible protocol for intracellular and surface marker-based detection of circulating tumor cells in hepatocellular carcinoma
Authors:
Open Access
- 7 November 2025
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-10
Abstract
Circulating tumor cell (CTC) detection in hepatocellular carcinoma (HCC) is limited not only by the rarity of CTCs but also by a heavy reliance on cell surface markers such as EpCAM, which are variably expressed or lost during tumor progression. Detecting intracellular markers, such as cytokeratin offers an important complementary and comprehensive strategy but remains technically limited in flow cytometry due to the need for fixation and permeabilization, which often lead to cell loss and surface epitope damage. In this study, we systematically evaluated the feasibility of using fixed samples for flow cytometry, using HepG2 cells, PBMCs, and CTCs from patients with HCC. Our results demonstrate that fixation enabled intracellular staining without compromising cell surface marker detection, even after short-term storage at 4 °C and long-term storage at -80 °C. Fixed samples, particularly fixed unfrozen, exhibited comparable staining performance to fresh samples with only a 7–10% reduction in cell recovery. Clinical validation in HCC patients confirmed successful CTC detection, and tumor-specific CTNNB1 mutations were identified in CTC-derived DNA but not in matched plasma cfDNA. These findings support fixed CTC sample workflows as a reliable and practical approach for CTC analysis in HCC.Keywords
Funding Information
- National Institutes of Health (U01CA275648, K08CA237624-01A1)
- Congressionally Directed Medical Research Programs (W81XWH-20-1-0605)
This publication has 24 references indexed in Scilit:
- The GLOBOCAN 2022 cancer estimates: Data sources, methods, and a snapshot of the cancer burden worldwideInternational Journal of Cancer, 2024
- Overcoming fixation and permeabilization challenges in flow cytometry by optical barcoding and multi‐pass acquisitionCytometry Part A, 2024
- Detection of Circulating Tumor Cells and Their Implications as a Biomarker for Diagnosis, Prognostication, and Therapeutic Monitoring in Hepatocellular CarcinomaHepatology, 2021
- Hepatocellular Carcinoma–Circulating Tumor Cells Expressing PD‐L1 Are Prognostic and Potentially Associated With Response to Checkpoint InhibitorsHepatology Communications, 2020
- A global view of hepatocellular carcinoma: trends, risk, prevention and managementNature Reviews Gastroenterology & Hepatology, 2019
- Detection of circulating tumor cells from cryopreserved human sarcoma peripheral blood mononuclear cellsCancer Letters, 2017
- Challenges in circulating tumour cell researchNature Reviews Cancer, 2014
- Multicolor detection of rare tumor cells in blood using a novel flow cytometry‐based systemCytometry Part A, 2013
- Validation of a multiparameter flow cytometry method for the determination of phosphorylated extracellular‐signal‐regulated kinase and DNA in circulating tumor cellsCytometry Part A, 2012
- A simple multicolor flow cytometry protocol for detection and molecular characterization of circulating tumor cells in epithelial cancersCytometry Part A, 2012